Showing 1 to 1 of 1 results
napoli.repubblica.it
🌐 90% Global Worthiness


ChemoID Test Significantly Improves Outcomes for Platinum-Resistant Ovarian Cancer
A phase 3 clinical trial published in Nature Partner Journal "Precision Oncology" demonstrates that the ChemoID test, analyzing tumor stem cells to guide chemotherapy selection, significantly improves response rates (50% vs 5%) and progression-free survival (11 months vs 3 months) in patients with p...
ChemoID Test Significantly Improves Outcomes for Platinum-Resistant Ovarian Cancer
A phase 3 clinical trial published in Nature Partner Journal "Precision Oncology" demonstrates that the ChemoID test, analyzing tumor stem cells to guide chemotherapy selection, significantly improves response rates (50% vs 5%) and progression-free survival (11 months vs 3 months) in patients with p...
Progress
48% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results